Most responders are good at describing someone else's emergency. Describing your own, in a fifteen-minute appointment, to a doctor who is typing while you talk, is a different skill. This piece gives you actual words to use when the question on your mind is not only "is there something else I can try" but "can it fit around the job."
Why the setting question belongs in the exam room
This summer our publisher paid for a poll of 443 Midwest adults, spread over ten states, on how they think about newer depression care. On the question of how they would like to get something like ketamine or esketamine, the largest group, 44 percent, picked an in-person clinic near home. Telehealth at home drew 22 percent. Another 23 percent wanted a hybrid, starting in a clinic and continuing from home, while 11 percent did not mind. These are whole-sample numbers from the final validated data; responders themselves, 29 people even with veterans counted in, were too few to report separately.
Stack the clinic-only and hybrid answers and you get 67 percent, combined, who wanted a clinic in the picture somewhere. That fits how the one FDA-approved option in this category works.
Trust runs the same way: 74 percent of respondents named their own doctor's advice as the push toward something new, while ads moved 2 percent. The appointment you are dreading is the most influential conversation in this whole process.
Before you go: three facts to have straight
- Spravato, the brand name for esketamine, carries FDA approval for depression that standard drugs have not relieved. The nasal spray is administered only inside a certified healthcare setting, with a stretch of observation afterward.
- Using IV ketamine against depression is off-label. Some clinics offer it, often for cash. Brain Recovery Centers explains how Spravato sessions work if you want the approved option's details beforehand.
- At-home ketamine through telehealth companies is a separate category with less oversight. It is not the same thing as Spravato and should not be discussed as if it were.
The script
Adjust the wording until it sounds like you. The structure is what matters: symptoms, history, schedule, then the ask.
Open with the problem, not the treatment.
"I want to use this visit for my mood. I have been low for a long time, and it is affecting my sleep and how I am at work and at home. I do not want to leave today without a plan."
Give the history plainly.
"I have tried [name the medications, or say 'two different antidepressants'] for [how long]. They either did not help or the side effects were too much. I have also done [counseling, peer support, EAP sessions, or nothing yet]."
If you cannot remember names or doses, say so and ask the office to pull them. That history is what determines whether your case counts as treatment-resistant depression, and it matters more than anything you read online.
Describe the job as a medical factor.
"I work rotating shifts as a [firefighter, paramedic, officer, dispatcher]. Some weeks I am on nights. Whatever we try, I need to understand how it fits that schedule, and whether it affects my ability to work or drive."
Sleep disruption, call exposure, and fitness-for-duty questions all shape which options make sense.
Ask the direct question.
"I keep seeing esketamine mentioned for people whose medications stopped working. Might I qualify for it? If not, what would you suggest instead, and why?"
Then ask about setting.
"If it is something I would need to do in a clinic, how often would I have to go, and for how long each time? Is there a version of my care where some visits could happen by video?"
Follow-up questions that save you a second appointment
- "Could you send me to a psychiatrist who offers this, or who can evaluate me for it?"
- "Will my insurance likely need prior authorization, and will your staff file it?"
- "If I do this, what do I tell my department, if anything? Would you write a note limited to scheduling, without my diagnosis?"
Insurance is not a side question. Our survey found 85 percent ranking "covered by insurance" among their two biggest provider factors, and just over half would rather jump through a plan's hoops than pay cash for an easier route.
What to do if the doctor says no, or does not know
You may hear "I am not familiar with that." That is not a closed door. Treatments in this category are new enough that many primary care offices do not handle them directly. Ask for a psychiatry referral and let the specialist evaluate you. Nearly a quarter of our respondents, 23 percent, would go directly to a psychiatrist or similar specialist as their opening move.
You may also hear a clear no, with a reason. Ask the doctor to explain it, and ask what they would try instead. A good answer will reference your history, your other conditions, or the medications you take. A no is a medical judgment, and it deserves a real explanation.
If you get brushed off with neither, asking for a second opinion is reasonable.
A note on the telehealth pitch
At-home ketamine ads promise convenience, and for a responder working nights that pitch lands. Before signing up, bring it to your doctor and say: "Here is what this company offers. What do you think of it for someone like me?" A physician who knows your history, medications, and alcohol use can weigh the risk in a way an intake questionnaire cannot.
Treat this as information, not medical advice; no treatment arrives with a promised result. The goal of the script is simple: to walk out with a next step, and to make sure the person who knows you best, medically, is part of the decision.
If the job has brought you to where ending your life has crossed your mind, please do not save that for an appointment. Text or call 988 and a trained Suicide and Crisis Lifeline counselor will answer, around the clock. Calling for backup is standard procedure on scene, and it is standard here too.
Methodology
This site's publisher commissioned the study and footed its cost. It went out via Pollfish's consumer panel; when collection ended on June 23, 2026, the count stood at 443 respondents, all adults 18 to 64 in Oklahoma, Ohio, Minnesota, Kansas, Illinois, Nebraska, Indiana, Missouri, Iowa, and Wisconsin. The sample was general population rather than responders alone, and Pollfish has validated it; these are the final whole-sample figures.